Two distinct Fas-activated signaling pathways revealed by an antitumor drug D609
被引:0
作者:
Lilin Zhang
论文数: 0引用数: 0
h-index: 0
机构:Osaka University Medical School,Laboratory of Molecular Genetics, Department of Post
Lilin Zhang
Shigeomi Shimizu
论文数: 0引用数: 0
h-index: 0
机构:Osaka University Medical School,Laboratory of Molecular Genetics, Department of Post
Shigeomi Shimizu
Yoshihide Tsujimoto
论文数: 0引用数: 0
h-index: 0
机构:Osaka University Medical School,Laboratory of Molecular Genetics, Department of Post
Yoshihide Tsujimoto
机构:
[1] Osaka University Medical School,Laboratory of Molecular Genetics, Department of Post
[2] Solution Oriented Research for Science and Technology (SORST),Genomics and Diseases
[3] Japan Science and Technology Corporation,undefined
来源:
Oncogene
|
2005年
/
24卷
关键词:
apoptosis;
Bak;
Bax;
mitochondria;
Fas;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
During the process of death receptor-mediated apoptosis, Bid is cleaved by activated caspase-8, and then cleaved Bid conveys apoptotic signals to the mitochondria by activating Bax/Bak. In the present study, we found that D609 (an antitumor drug with multiple activities) blocks Fas-induced apoptosis. D609 did not interfere with activation of caspase-8 and cleavage of Bid, whereas it blocked cytochrome c release from the mitochondria by inhibiting the activation of Bax and Bak. D609 had no protective effect against apoptosis of SKW6.4 cells, which are typical type I cells. Studies using permeabilized cells revealed that in addition to activation of caspase-8, Fas activated a distinct and D609-sensitive signaling pathway that transmitted signal(s) sensitizing the mitochondria to apoptotic stimuli, and that D609 itself promoted mitochondrial resistance to apoptotic stimuli.